WEDNESDAY, JUNE 7TH

DARCLEE HALL
16:00-18:00 PRE-CONGRESS COURSE:
PUMPS, SENSORS and CLOSED LOOP HYBRID SYSTEMS. ADVANCED COURSE PART 1
Programme Director: Assoc. Prof. Anca Pantea Stoian

Speakers & Trainers:

Prof. Andrej Janez
Attila Detary – Diabetes T&E Leader CEMA

16:00-16:20 Introduction. Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: The Position
Statement for Clinical Use in Central and Eastern Europe

16:20-16:35 From MDI to CSII – Calculation of insulin doses. Trips and tricks.

16:35-16:50 Insulin Sensitivity and Carbohydrate Ratio for insulin pumps.

16:50-16:55 How to set the daily basal pattern.

16:55-17:10 Active Insulin – what does it mean?

17:10-17:30 Dual Wave VS Square Wave Bolus.

17:30-17:45 Temporary basal rate – when to use it.

17:45-18:00 CareLink reports

18:00-18:20 COFFEE BREAK
18:20-20:20 PUMPS, SENSORS and CLOSED LOOP HYBRID SYSTEMS. ADVANCED COURSE PART 2
Programme Director: Assoc. Prof. Anca Pantea Stoian

Speakers & Trainers:

Prof. Andrej Janez
Attila Detary – Diabetes T&E Leader CEMA

1
Hands-on series of case studies.

• Hypoglycemia. Adaptation of boluses to hypoglycemia.

• Hyperglycemia. Adaptation of boluses to hyperglycemia.
• Setting the pump in particular situations. Examples and practical exercises.
• Side effects.
The reports are delivered by the pump. Their analysis and interpretation. Practical exercises. Models.

2
 THURSDAY, JUNE 8TH
CONFERENCE ROOM 1 – NEW YORK HALL
08:45-09:55 SCIENTIFIC SESSION I: DIABETES NEUROPATHY
Chairs: Prof. Peter Kempler, Dr. Anna Körei

08:45-09:00 Environmental risk factors of incident distal sensorimotor polyneuropathy

Christian Herder

09.00-09.15 Diabetic neuropathy - the neglected complication of diabetes

Boris Mankovski

09:15-09:30 Diabetic autonomic neuropathy of the gastrointestinal tract - current status and future perspectives
Mihaela Vladu

09:30-09:45 Is there a relationship between diabetic neuropathy and depression?

Eva Kadar
09:45-09:55 Discussions
09:55-11:20 SCIENTIFIC SESSION II: TYPE 2 DIABETES
Chairs: Prof. Maria Mota, Prof. Avivit Cahn
09:55-10:10 Pathophysiology of type 2 diabetes - novel aspects
Dario Rahelic

10:10-10:25 Should GLP1/GIP RA be used in ALL patients with diabetes?

Avivit Cahn

10:25-10:40 Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Cardiovascular Risk
Maria Mota

10:40-10:55 Implementation of metabolic surgery as a broader approach to control the type 2 diabetes epidemic
José Silva-Nunes

10:55-11:10 Time in range and diabetic complications: Which evidence?

Antonio Ceriello

11:10-11:20 Discussions

3
11:20-11:50 COFFEE BREAK
CONFERENCE ROOM 1 – NEW YORK CONFERENCE ROOM 2 – MEXICO & SEOUL
11:50-13:00 SCIENTIFIC SESSION III: 11:50-13:00 YOUNG INVESTIGATOR'S SESSION 1
CARDIODIABETES Chairs: Prof. Bogdan Timar, Prof. Robert
Chairs: Prof. Dragos Vinereanu, Wagner
Prof. Francesco Cosentino
11:50-12:05 Considerations in the Use and Interpretation of
11.50-12.05 The novel therapeutical approach in CGMS Systems
Dislipdemia Latife Bozkurt
Dragos Vinereanu
12:05-12:20 Atherosclerotic cardiovascular disease in
12.05-12.20 ESC and EASD updates of diabetes patients with type 2 Diabetes Mellitus-
guidelines therapeutic perspectives
Francesco Cosentino Cristina Bica

12.20-12.35 Imaging in diabetic cardiomyopathy 12:20-12:35 Declaration of In(ter)dependence -

Bogdan Alexandru Popescu Telemedicine, Diabetes Mellitus and
Cardiovascular Disease
12.35-12.50 Variability of risk factors and Laura Gaita
cardiovascular diabetic complications
Antonio Ceriello 12:35-12:50 Clinical significance of visceral adipose tissue
and the role of GLP1-RAs.
12.50-13.00 Discussions Angelo Maria Patti

12:50-13:00 Discussions
13:00-14:00 LUNCH BREAK
14:00-15:10 CEDA & IAS SESSION JOINT SESSION 14:00-15:20 SCIENTIFIC SESSION IV: TYPE 1 DIABETES
Chairs: Prof. Michal Vrablik, Prof. Chair: Prof. Martin Haluzik, Prof. Tomasz Klupa
Thomas Stulnig
14:00-14:15 Adjunct therapy in T1DM – The Renaissance?
14:00-14:15 Novel approaches to dyslipidemia Tomasz Klupa
management
Michal Vrablik

4
14:15-14:30 The role of Lp(a) in enhancing the CV 14:15-14:30 Clinical characteristics and cardiovascular risk
risk in diabetic patients profile in children and adolescents with latent
Zlatko Fras autoimmune diabetes (LADY) in comparison to
pediatric type 1 diabetes and type 2 diabetes:
14:30-14:45 Antidiabetic agents and results from the German/Austrian Prospective
atherosclerotic CVD Diabetes Follow-up Registry
Manfredi Rizzo Oana Patricia Zaharia/Nanette Schloot

14:45-15:00 Managing dyslipidaemia in type 2 14:30-14:45 Hybrid closed-loop insulin pumps in the
diabetes mellitus. treatment of diabetes: Where do we go from
Ronen Durst there?
Martin Haluzik
15:00-15:10 Discussions
14:45-15:00 Integrating diabetes technology- a Romanian
educational programme to overcome clinical
inertia
Delia Reurean Pintilei

15:00-15:15 Implantable glucose monitoring sensors.

Sorin Ioacara

15:15-15:20 Discussions

15:10-16:10 PARTNER SYMPOSIUM

16:10-17:20 SCIENTIFIC SESSION V: NAFLD, NASH 16:30-17:00 POSTER SESSION 1
AND DIABETES Chairs: Dr. Latife Bozkurt, Assoc. prof. Mihaela
Chairs: Prof. Corina Silvia Pop, Prof. Vladu
Dario Rahelic
1. Similar HbA1c reduction with GLP1RA and
16:10-16:25 Non-alcoholic fatty liver disease in SGLT2i treatment intensification strategy in
diabetes: a practical approach to type 2 diabetes patients - a prospective
diagnosis and staging study in ambulatory clinics
Corina Silvia Pop Roxana Adriana Stoica, Maria Camelia
Sandu, Nardin Ka'Biya, Anca Pantea Stoian
16:25-16:40 Diabetes and MAFLD

5
 Dario Rahelic 2. The combination of an SGLT2 inhibitor with
finerenone – what do we know so far?
16:40-16:55 Metabolic liver disease in diabetes Laura Girdan, Roxana Adriana Stoica
Bogdan Mihai
3. The benefits of total body fat loss on liver
MAFLD treatment and novel fibrosis and steatosis after dapagliflozin in
antidiabetic drugs: Is there a light at patients with type 2 diabetes
16:55-17:10 the end of the tunnel? Adina Braha, Bogdan Timar, Alina Popescu,
Manfredi Rizzo/Niki Katsiki Camelia Foncea, Radu Cotrău, Lucian
Vasiluță, Daniela Cipu, Romulus Timar
17:10-17:20 Discussions
4. Dysmetabolism-related early peripheral
sensory dysfunction and its relationship to
the development of diabetic peripheral
neuropathy.
Dimitrios Tsilingiris, Lukas Schimpfle,
Ekaterina von Rauchhaupt, Alba Sulaj, Lukas
Seebauer, Hannelore Bartl, Stephan Herzig,
Julia Szendroedi, Stefan Kopf, Ζoltan Κender
5. Association between serum uric acid with
diabetes and liver steatosis
Simona Popescu, Teodora Sorescu, Laura
Gaita, Adriana Ivanescu, Romulus Timar,
Bogdan Timar

17:00-17:20 PARTNER SYMPOSIUM

17:20-17:40 COFFEE BREAK

6
 CONFERENCE ROOM 1 – NEW YORK CONFERENCE ROOM 2 – MEXICO & SEOUL
17:40-19.00 PARTNER SYMPOSIUM 17:40-18:50 YOUNG INVESTIGATOR'S SESSION 2
Chairs: Prof. Maria Mota, Dr. Djordje Popovic

17:40-17:55 Type 1 diabetes mellitus in the era of novel

antidiabetic drugs: Is the insulin therapy still
sufficient?
Djordje Popovic

17:55-18:10 Sensors in diabetes: it's not all about glucose!

Roxana Stoica

18:10-18:25 Once-weekly subcutaneous semaglutide use in

GLP-1 naïve patients with type 2
diabetes in North Macedonia: Real-world data
from the MIRAGE study
Irfan Ahmeti

18:25-18:40 Real-life Preliminary Data on Cardioprotective

Molecules in Diabetes
Teodor Salmen
18:40-18:50
Discussions
19.20 Pullman Central Hall
TRANSFER FOR DINNER CEREMONY to Natura Cocktail Baroque Events and Garden and return
(for all participants)

20.00-22.30 CEREMONY & DINNER: PARTNERSHIP FOR DIABETES

Natura Cocktail Baroque Events and Garden

Welcome :
Prof. Peter Kempler – President of CEDA/FID
Assoc. Prof. Anca Pantea Stoian – Chairman of the organizing committee of CEDA 2023 & Vice-
President Elect of CEDA/FID

7
 FRIDAY, JUNE 9TH
CONFERENCE ROOM 1 – NEW YORK CONFERENCE ROOM 2 - MEXICO & SEOUL
08:50-10:00 SCIENTIFIC SESSION VI: NOVEL THERAPY 09:00-10:10 SCIENTIFIC SESSION VII: CARDIOMETABOLIC
IN TYPE 2 DIABETES ASPECTS OF DIABETES
Chairs: Prof. Francesco Giorgino, Prof. Chair: Prof. Doina Catrinoiu, Prof. Neboja
Bogdan Timar Lalic

08:50-09:05 Weight effect of incretin polyagonists 09:00-09:15 Insulin Resistance: the beginning or the
Cristian Guja end?
Doina Catrinoiu
09:05-09:20 CV risk in type 2 diabetes. The need for a
holistic approach 09:15-09:30 Lp(a) in diabetes: current evidence and
Stefano del Prato future perspectives
Michal Vrablik/Niki Katsiki
09:20-09:35 GLP-1/GIP/Glucagon Multiagonists and
Potential Cardiorenal Protection 09:30-09:45 The role of insulin resistance revisited: Is it
Francesco Giorgino still a therapeutic target?
Neboja Lalic
09:35-09:50 The future of metabolic therapies
Bogdan Timar 09:45-10:00 Diabetic cardiomyopathy: What's new?
Irinel Raluca Parepa
09:50-10:00 Discussions
10:00-10:10 Discussions
10:00-11:10 SCIENTIFIC SESSION VIII: METABOLIC 10:10-11:20 SCIENTIFIC SESSION IX: OBESITY
AND EXTRA METABOLIC EFFECTS OF Chairs: Prof. Catalina Poiana, Prof. Andrej
GLP1 RA Janez
Chairs: Prof. Michael Nauck, Prof.
Manfredi Rizzo 10:10-10:25 Obesity care in Romania – strategy of
Romanian Obesity Forum
10.00-10.15 Comparative effectiveness and Nicolae Hancu/Cornelia Bala/Catalina
tolerability of GLP-1 RA for type 2 Poiana
diabetes
Michael Nauck

8
10.15-10.30 Anti-Atherosclerotic mechanisms of GLP- 10:25-10:40 GLP 1 in Obesity
1RAs Andrej Janez
Manfredi Rizzo
10:40-10:55 Obesity and the risk of Cancer
10.30-10.45 Renal protection of GLP1 RA Catalina Poiana
Bogdan Timar
10:55-11:10 The Future in the Pharmaceutical
10.45-11.00 Extrametabolic effects of GLP1 RA Treatment of Obesity
Anca Pantea Stoian Erifili Hatziagelaki

11.00-11.10 Discussions 11:10-11:20 Discussions

11:10-11:30 PARTNER SYMPOSIUM 11:20-12:00 PARTNER SYMPOSIUM

11:30-12:00 PARTNER SYMPOSIUM

12:00-12:20 COFFEE BREAK

12:20-13:30 SCIENTIFIC SESSION X: DIABETES AND 12:20-13:00 PARTNER SYMPOSIUM
KIDNEY
Chairs: Prof. Roger Lehman, Prof. 13:00-13:30 POSTER SESSION 2
Cristian Serafinceanu Chairs: Prof. Simona Cernea, Prof. Robert
Wagner
12:20-12:35 Modern treatment of chronic kidney
disease in diabetes mellitus 1. Impact of laparoscopic sleeve
Roger Lehmann gastrectomy on metabolic homeostasis
and nutritional deficiencies: long-term
12:35-12:50 Mechanisms of cardiac and renal effects follow-up
of SGLT2i Simona Georgiana Popa, Rubin
Michael Roden/Oana Patricia Zaharia Munteanu, Cornelia Zetu

12:50-13:05 HTA resistance in the CaReMe patient 2. Impact of Liraglutide 3.0 mg for Weight
Adrian Covic Management among Women with

9
13:05-13:20 Bone and mineral disorder in CKD Obstetrics and Gynaecology-Related
Cristian Serafinceanu Complications “OG-RC
Majed Alhudhud, Maab Elhussein, Nabila
13:20-13:30 Discussions Abu Tahoun, Nehad Thabet

3. Complications of sequenced bariatric

interventions – a clinical case
Andreea Herascu, Avram Vlad Florian,
Sima Alexandra Christa, Timar Romulus
Bogdan

4. The economic impact of obesity in 4

selected South-Eastern European
countries: Healthcare resource use and
costs associated with obesity-related
complications
C. Bala, K. Athanasakis; A. Kokkinos; G.
Simonyi; K. Hálová Karoliová; A. Basse;
M. Bogdanovic; M. Kang; K. Low; A. Gras

5. Sleep apnea syndrome in patients with

and without diabetes type 2
Catalina Mocanu, Harea Dumitru

6. Effect of semaglutide on subclinical

atherosclerosis and cardiometabolic
compensation: a real-world study in
patients with type 2 diabetes.
Angelo Maria Patti, Giglio Rosaria
Vincenza, Stoian Anca Pantea, Allotta
Alberto, Lo Sciuto Antonino, Cottone
Carlo Domenico, Di Bella Tommaso,
Bruno Andreina, Ciaccio Marcello, Rizzo
Manfredi

10
13:00-13:30 POSTER SESSION 3 ON THE HALL
Chairs: Assoc. Prof. Mihaela Vladu, Assoc.
Prof. Mihaela Popovici

1. Vitamin B12 deficiency in Diabetes

Mellitus type 2 patients during
treatment with Metformin.
Entela Puca, Edmond Puca

2. Very high-risk Type 2 Diabetes Mellitus

patients in a tertiary-care centre: a
comparative analysis
Valeria-Anca Pietrosel, Teodor Salmen,
Cristina Ioana Bica, Cosmina Theodora
Diaconu, Anca Pantea-Stoian

3. Effect of semaglutide versus other GLP-

1RAs on glycemia and other cardio-
metabolic risk factors among subjects
with type 2 diabetes mellitus: a
systematic review and meta-analysis of
head-to-head, phase 3, randomized
controlled trials.
Dimitrios Patoulias, Djordje S. Popovic,
Manfredi Rizzo

4. Neutrophil-to-lymphocyte ratio - a
reliable marker for prediction of
Diabetes Macrovascular complications
Maria Botan, Mihalcea Maria, Dorita
Alina, Diaconu Cosmina, Salmen Teodor,
Pietroșel Anca, Bica Cristina, Pantea-
Stoian Anca

11
 5. Prevalence and Determinants of
Hyperuricemia in Type 2 Diabetes
Mellitus Patients
Maria Mihalcea, Botan Maria, Dorita
Alina, Diaconu Cosmina, Salmen Teodor,
Pietroșel Anca, Bica Cristina, Pantea-
Stoian Anca

6. Non-alcoholic fatty liver disease in

Type 2 Diabetes Mellitus- An
observational study
Cosmina Diaconu, Salmen Teodor ,
Pietroșel Anca, Bica Cristina, Botan
Maria, Mihalcea Maria, Pantea Stoian
Anca
13:30-14:20 LUNCH BREAK
14:20-15:30 PARTNER SYMPOSIUM 14:20-15:30 SCIENTIFIC SESSION XI: DIABETES VARIA
Chair: Prof. Helmut Schatz, Prof. Thomas
Stulnig

14:20-14:35 History of Diabetes Treatment: From the

Ayurveda over Hippocrates, the medieval
monk's French lilac, Zuelzer, Paulescu and
Banting & Best to prediabetes: to treat or
not to treat?
Helmut Schatz

14:35-14:50 Updated on immunopreventive therapies in

type 1 diabetes: Is there more than
Teplizumab?
Oana Patricia Zaharia/Nanette Schloot
14:50-15:05 Looking to the Future: From Clinical
Medicine to Precision Medicine
Erifili Hatziagelaki

12
 15:05-15:20 SGLT2i or GLP1RA for cardiovascular
prevention?
Thomas Stulnig

15:20-15:30 Discussions
15:30-16:40 PARTNER SYMPOSIUM 15:30-16:10 POSTER SESSION 4
Chairs: Assoc. Prof. Mihaela Popovicu,
Dr. Djordje Popovic

1. How Effective are Anti-diabetic

Therapies in Controlling Glycemic Levels
and Body Composition in Type 2
Diabetes Mellitus Patients?
Ioana Paunica, Simona Ștefan, Doina
Andrada Mihai, Anca Pantea Stoian,
Cristian Serafinceanu

2. A complex investigation of the

metabolic abnormalities correlated with
obesity.
Catalina Railean

3. Implementing Pcsk9-i treatment in real-

world scenarios-brief experience from a
single centre
Anamaria Meauca, Maxim Valentina ,
Cureniuc Adrian, Ganga Mihai, Simiraș
Eliza, Apopei Diana, Reurean-Pintilei Delia

4. Left ventricular layer-specific

deformation in uncomplicated patients
with diabetes mellitus and acute
hyperglycemic episodes

13
 Jelena Bogdanović, Nebojša M. Lalić,
Milika Ašanin, Gordana Krljanac,
Aleksandra Jotić, Ivana Babić, Jelena
Milin, Dragana Popović, Katarina Lalić

5. Treatment of type 2 diabetes in clinical

practice: Are therapeutic targets met?
Teodora Sorescu, Popescu Simona,
Romulus Timar, Bogdan Timar

6. Nutritional management challenges in

a patient with gastric cancer and type 2
diabetes
Sorina Boariu , Ana Maria Scutariu,
Adrian Cureniuc, Ana Maria Meaucă,
Delia Reurean-Pintilei

POSTER SESSION 5 ON THE HALL

Chairs: Assoc. Prof. Cristina Lacatusu, Dr.
15:30-16:10 Oana Patricia Zaharia

1. Mody – From A Diabetologist’s And

Geneticist’s Perspective
Diana Apopei, Meaucă Anamaria,
Cureniuc Adrian, Ganga Mihai, Simiraș
Eliza, Maxim Valentina, Reurean-Pintilei
Delia

2. The impact of the COVID pandemic on

patients with diabetes
Ana-Maria Ciubuc, Ion-Vladut Udroiu,
Loredana Deaconu, Deiana Roman,
Bogdan Timar

14
 3. Insulin autoimmune syndrome – more
frequent than we are aware of?
Flavia Lupsa, Bianca Emanoil, Andreea
Chivaran, Vlad Avram, Bogdan Timar,
Alexandra Sima

4. Acute pancreatitis and concomitant

diabetes ketoacidosis: analysis of
potential risk factors
Ivana Babić, Aleksandra Jotić, Katarina
Lalić, Jelena Bogdanović, Dragana
Popović, Milica Stoiljković, Nebojša M.
Lalić

5. The Prevalence of Chronic Diseases

among Patients with Type Two Diabetes
Mellitus in King Abdulaziz National
Guard Hospital
AlAhasa Mansoor AlNaim

6. Real-life Data about the Safety of New

Antidiabetic Drugs (Sodium-Glucose
Cotransporter-2 Inhibitors and
Glucagon-Like Peptide 1 Receptor
Agonists)
Teodor Salmen, Ioana-Cristina Bica,
Anca-Valeria Pietrosel, Cosmina
Theodora Diaconu, Doina-Andrada
Mihai, Corina Pop, Anca Pantea Stoian
16:10-16:40 PARTNER SYMPOSIUM

16:40-17:00 COFFEE BREAK

15
17:00-18:00 PARTNER SYMPOSIUM 17:00-18:10 SCIENTIFIC SESSION XII: DIABETES, EYE AND
BRAIN
Chairs: Prof. Boris Mankovski, Prof. Martin
Prazny

17:00-17:15 Stroke in patients with diabetes mellitus

Boris Mankovski

17:15-17:30 Beneficial effects of a multi-nutrient

complex on retinal microcirculation in
diabetic patients assessed using adaptive
optics
Ioana Tofolean/Florin Balta

17:30-17:45 Artificial intelligence for the detection of

diabetes retinopathy
Martin Prazny

17:45-18:00 Non-diabetic hypoglycemia in clinical

practice
Jan Skrha

18:00-18:10 Discussions
18:00-18:55 SCIENTIFIC SESSION XIII: DIABETIC FOOT 18:10-18:55 POSTER SESSION 6
Chairs: Prof. Nikos Papanas, Prof. Chairs: Prof. Christian Herder, Dr Delia
Cornelia Bala Reurean Pintilei

18:00-18:15 Skin and musculoskeletal disorders of 1. Evaluation of psycho-emotional state,

diabetic neuropathy eating behaviour and self-care at home
Nikos Papanas of patients with diabetes mellitus
Denisa Pescari, Dana Stoian, Bogdan
18:15-18:30 Peripheral Artery Disease- another"
Timar
frequent, forgotten and often fatal"
complication of diabetes

16
 Cornelia Bala 2. Effect of Adherence to Therapy and
Health Plans in Achieving Diabetes
18:30-18:45 Nutraceutical approach to diabetic Control Among Diabetic People at King
neuropathy management Abdulaziz National Guard Hospital
Arrigo Cicero AlAhsa: Retrospective Study
Mansoor AlNaim
18:45-18:55 Discussions
3. Anxiety in hospitalized patients with and
without diabetes
Alina Gaina, Harea Dumitru

4. Quality of life in the course of one-year

advance hybrid closed-loop system use
in adults with type 1 diabetes previously
naive to diabetes technology – a
milestone in the treatment of diabetes
Katarzyna Cyranka, Bartłomiej Matejko,
Anna Juza, Beata Kieć-Wilk, Ohad Cohen,
Maciej T Malecki Tomasz Klupa

5. Six-month periodic fasting does not

affect somatosensory nerve function in
type 2 diabetes patients.
Zoltan Kender, Ekaterina von
Rauchhaupt, Daniel Schwarz, Dimitrios
Tsilingiris, Lukas Schimpfle, Hannelore
Bartl, Valter Longo, Martin Bendszus,
Stefan Kopf, Stephan Herzig, Sabine
Heiland, Julia Szendroedi, Alba Sulaj

6. Artificial Intelligence and ChatGPT in

Diabetes Management: Improving
Patient Outcomes and Reducing
Complications
Roxana Maria Farcas, Tilinca Mariana

17
 7. Surgical treatment for septic lesions of
the diabetic foot
Dan Dumitrescu, Florin Bobirca, Anca
Pantea Stoian, Lidia Belega, Cristina Bica,
Teodor Salmen, Traian Patrascu

8. The assessment of steatofibrosis in

patients with type 2 diabetes,
correlations with components of the
metabolic syndrome
Ștefan Ciucur, Andreea Niță, Claudiu
Sinteion, Bogdan Timar, Oana Albai

POSTER SESSION 7 ON THE HALL

18:10-18:55 Chairs: Assoc. Prof. Cristina Lacatusu, Assoc.
Prof. Mihaela Popoviciu

1. The challenge of achieving lipid targets

in Type 2 Diabetes Mellitus patients
with high cardiovascular risk and
established atherosclerotic
cardiovascular disease
Ioana-Cristina Bica, Valeria-Anca
Pietrosel, Teodor Salmen, Cosmina-
Theodora Diaconu, Anca Pantea Stoian

2. The current therapeutic approach in

Charcot osteoarthropathy
Dan Dumitrescu, Florin Bobirca, Anca
Pantea Stoian, Lidia Belega, Cristina Bica,
Teodor Salmen, Traian Patrascu

3. Finerenone in chronic kidney disease

and type 2 diabetes – old and new

18
 Laura Gîrdan, Roxana Adriana Stoica
4. Metformin associated lactic acidosis
(MALA)
Blertina Dyrmishi, Elvana Rista

5. Underutilization of statin therapy in

patients with diabetes mellitus, an
alarming truth
Vlad Florian Avram, Gaita Laura Adriana,
Timar Romulus Bogdan

6. Monoamine Oxidase (MAO)

Contribution to Vascular Hyperglycemic
Memory – Are MAO Inhibitors
Candidates for Drug Repurposing?
Adrian Sturza, Ionică N. Loredana, Raluca
Soșdean, Laura Gaiță, Simona Popescu,
Borza Claudia, Danina M. Muntean
19:20 Pullman Central Hall
TRANSFER FOR DINNER CEREMONY to Pentagon Events and return
(for all participants)

19.30-22.30 ROMANIAN SCIENCE CEREMONY & DINNER

Pentagon Events

19
 SATURDAY, JUNE 10TH
CONFERENCE ROOM 1 – NEW YORK
09:00-10:10 SCIENTIFIC SESSION XIV: PREDIABETES
Chairs: Prof. Tzvetalina Tankova, Prof. José Silva-Nunes

09:00-09:15 Prediabetic neuropathy

Nikos Papanas

09:15-09:30 How prediabetes should be faced in current times

José Silva-Nunes

09:30-09:45 Complications in prediabetes

Tvetalina Tankova

09:45-10:00 Precision medicine in prediabetes

Robert Wagner

10:00-10:10 Discussions
10:10-11:10 PARTNER SYMPOSIUM
11:10-11:30 COFFEE BREAK
11:30-12:20 SCIENTIFIC SESSION XV: DIABETES AND SURGERY
Chairs: Prof. Cynthia Formosa, Lecturer. Florin Bobirca

11:30-11:45 The importance of a biomechanical evaluation of the diabetic foot pre-and post-surgical interventions
Cynthia Formosa

11:45-12:00 Thermographic and biomechanical aspects in the diagnosis and management of diabetic foot
complications.
Alfred Gatt

12:00-12:15 Surgical particularities in neuropathic diabetic foot

Florin Bobirca

12:15-12:20 Discussions

20
 CONFERENCE ROOM 1 – NEW YORK CONFERENCE ROOM 2 - MEXICO & SEOUL
12:20-13:20 PARTNER SYMPOSIUM 12:20-13:40 SCIENTIFIC SESSION XVI: DIABETES AND ITS
COMPLICATIONS
Chairs: Prof. Gabriela Roman, Prof. Katarina
Lalic

12:20-12:35 Weight management in type 2 diabetes - a

primary therapeutic objective
Gabriela Roman

12:35-12:50 Insulin receptors isoforms in gestational

diabetes
Simona Georgiana Popa

12:50-13:05 Non-surgical strategies for the remission of

type 2 diabetes
Simona Cernea

13:05-13:20 Familial hypercholesterolemia: challenges

in diagnosis and treatment
Katarina Lalic

13:20-13:35 The fawn response to an unsuccessful

battle: the metabolically healthy obese
phenotype
13:20-13:50 PARTNER SYMPOSIUM Cristina Mihaela Lacatusu

13.35-13.40 Discussions
13:50-14:40 LUNCH BREAK
14:40-15:50 SCIENTIFIC SESSION XVII: GYNAECOLOGY 14:40-15:50 YOUNG INVESTIGATOR'S SESSION 3
AND ENDOCRINOLOGY IN DIABETES Chairs: Prof. Julia Szendrodi, Assoc. Prof.
Chairs: Prof. Catalina Poiana, Assoc. Mihaela Popoviciu
Prof. Diana Loreta Paun

21
14:40-14:55 Diabetes and infertility 14:40-14:55 The study of heart failure with mildly
Catalina Poiana reduced ejection fraction in patients with
type 2 diabetes
14:55-15:10 Erectile dysfunction in diabetes Adina Mitrea
Tamás Várkonyi
14:55-15:10 A patatin-like phospholipase domain-
15:10-15:25 Hormonal therapy and diabetes containing 3 gene variant is more prevalent
Diana Loreta Paun with declining kidney function in people
with recent-onset diabetes.
15:25-15:40 Polycystic ovary syndrome is the most Oana Patricia Zaharia
frequent endocrine-metabolic disease of
women, with insulin resistance in the 15:10-15:25 Microbiome and Metabolome Patterns in
background and several controversies of Type 1 Diabetes
diagnosis and treatment. Gratiela Gradisteanu Parcalabioru
Gyula Petranyi

15:40-15:50 Discussions Beyond LDL-c target: The association

15:25-15:40 between ApoA1 and ApoB levels and
cardiovascular risk in patients with type 2
diabetes
Ioana Păunică

Discussions
15:40-15:50
16:00-16:30 GENERAL ASSEMBLY NEW YORK CONGRESS HALL
16:30-17:00 CLOSING CEREMONY & AWARDS

CONFERENCE ROOM 2 - MEXICO & SEOUL

16:00-19:20 DIABETES CLINICAL NUTRITION MASTER COURSE

Programme director: Prof. Arrigo Cicero, Assoc. Prof. Anca Pantea Stoian, Dr. Delia Reurean Pintilei

1. Introduction in clinical nutrition: Assoc. Prof. Anca Pantea Stoian, Prof. Arrigo Cicero, Dr. Delia
Reurean Pintilei

22
 The scientific concept of a healthy diet

2. Medical Nutrition assessment: Evaluate and monitor the patient

Dr. Delia Reurean Pintilei

✓ anthropometric
✓ laboratory parameters
✓ impedentiometry
✓ questionnaires

3. Scientific approaches to different types of diets/nutrition intervention

Prof. Arrigo Cicero

✓ Low-carb Med,
✓ VLCKD,
✓ Paleo Diet,
✓ Intermittent fasting
4. Nutraceutical compounds used in diabetes and its complications:
Prof. Arrigo Cicero

✓ Nutraceuticals' effect on fasting plasma glucose and insulin-resistance

✓ Nutraceutical approach to diabetic neuropathy

5. Preliminary aspects to consider when you establish a diet

Dr. Delia Reurean Pintilei

✓ Healthy people versus people with diabetes and its complications.

✓ Perfect nutrition intervention to prevent diabetes and other cardiometabolic
diseases

6. Hands-on All the participants

✓ Develop an integrated nutrition intervention plan for patients with diabetes

23
24